Can someone explain15 Mar 2024 14:41
Sorry my question regarding the loan of 5 million from march 2023 was badly worded and I couldn't understand what I had asked lol
So this was from January RNS
"genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, today announces a further scheduled £600,000 draw down under the terms of the £5m Equity Prepayment Facility, which was previously announced by the Company on 31 March 2023. Investors have been granted 3,093,915 warrants equal to 40% of this drawdown divided by the Reference Price of 7.7572 pence. The exercise price of the warrants payable to the Company will be 140% of the Reference Price equating to 10.86 pence."
My question at the time of this 5 million equity prepayment is
A] how much is left to draw down of this 5 million
B] could they do something similar this march/April
C] when it came in to play in March 2023 just how dilutive was it to shareholders. Did it dilute the SP straight away or only when they actually drew money from the 5 million
Thanks in advance for the replies